about
Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developmentsLymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processesEstablishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease.Infections and Follicular Lymphoma: is there a Link?Metagenomic detection of viruses in aerosol samples from workers in animal slaughterhousesEpstein-Barr virus-positive T/NK-cell lymphoproliferative disordersHodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.Diagnosis and management of lymphomas and other cancers in HIV-infected patients.Toll-like receptors in the pathogenesis of human B cell malignancies.The role of microRNAs in the pathogenesis of HIV-related lymphomas.An Autopsy Case of Epstein-Barr Virus‒Associated Diffuse Large B-Cell Lymphoma of the Central Nervous System in an Immunocompromised Host.Toll-like receptors targeting technology for the treatment of lymphoma.Pathogenesis and FDG-PET/CT findings of Epstein-Barr virus-related lymphoid neoplasms.Association of DDX58 177 C > T polymorphism with decreased risk of Epstein-Barr virus-related nodular sclerosis classical Hodgkin lymphoma.In Europe expression of EBNA2 is associated with poor survival in EBV-positive diffuse large B-cell lymphoma of the elderly.Clinical characteristics and treatment outcome in a Taiwanese population of patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders.Secondary Hemophagocytic Syndrome Associated with Richter's Transformation in Chronic Lymphocytic Leukemia.In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications.Spontaneous remission of chemo-immunotherapy related, non-transplant Epstein-Barr virus-associated lymphoproliferative disorder in a patient with chronic lymphocytic leukemia.Extranodal Natural Killer/T-Cell Lymphoma: A Rare Nasal-Type Case.Impact of Chronic Viral Infection on T-Cell Dependent Humoral Immune Response.
P2860
Q26775442-AED67D85-335C-4804-8038-831FBE7392EDQ28271456-69A33E9D-4100-422D-A24E-6CEBF781DF31Q33456742-2BD3D2DC-163A-4CE7-A3C2-CD8D37ACEB8BQ33642185-6048E06E-CB3D-4B5B-ADD6-42F9BBF625C7Q34964997-7EC198A0-3F9C-486F-8833-F2E686F97953Q35040638-03C1BF93-35D3-436D-84A4-1047625E94D3Q35626311-24AA9731-77BE-48E9-86E1-82303E7C5764Q38194845-52BFDB76-BC0C-418B-B0AE-8493F11FD44EQ38238963-CD04F2BE-BEF4-40EB-A642-161678515F10Q38555990-A64A192D-B8F3-4337-ADD9-18943E3F5720Q38647278-F02182DA-D5E0-4AA9-82D8-879CC8F52932Q38948266-2A56EA28-8777-49DA-9854-3DCD195D9BC6Q39301790-4BB1B3A8-659D-4326-8721-1F60D23D0D1AQ40643670-0FEC7859-DBBC-4A90-907D-A0014B840DFEQ41300276-98E5A6E4-5E36-45E9-9DAF-3956021F935AQ41699036-A3FA8358-2862-4987-8FAB-30B076B8FFD2Q41728703-E8B5EC0F-C352-47CE-8F3F-0EC375477DF1Q41863172-17897091-7276-475F-A3F6-22A2FD167592Q42222507-2C04B4F3-9B17-4A1A-BC8B-0A68E1E576BBQ42739833-95D73DB4-35FE-418D-9575-D220482E7CADQ42937767-97128896-CFEF-454F-ABA4-9167180B855BQ47148419-30621F01-825E-40D1-BE6E-6F3D85224F41
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
EBV-associated lymphomas in adults
@ast
EBV-associated lymphomas in adults
@en
EBV-associated lymphomas in adults
@nl
type
label
EBV-associated lymphomas in adults
@ast
EBV-associated lymphomas in adults
@en
EBV-associated lymphomas in adults
@nl
prefLabel
EBV-associated lymphomas in adults
@ast
EBV-associated lymphomas in adults
@en
EBV-associated lymphomas in adults
@nl
P2860
P1476
EBV-associated lymphomas in adults
@en
P2093
Wyndham H Wilson
P2860
P356
10.1016/J.BEHA.2012.01.005
P577
2012-02-05T00:00:00Z